U.S. tech giants have backed a German company in its latest fundraising round to develop its humanoid robotics tech. Neura Robotics' Series C financing, which is worth up to $1.4 billion, featured Tether, Qualcomm, Amazon and Nvidia, alongside European industrial companies Bosch and Schaeffler and the European Investment Bank. The company hit a valuation of around $7 billion, according to a source...
U.S. tech giants have backed a German company in its latest fundraising round to develop its humanoid robotics tech. Neura Robotics' Series C financing, which is worth up to $1.4 billion, featured Tether, Qualcomm, Amazon and Nvidia, alongside European industrial companies Bosch and Schaeffler and the European Investment Bank. The company hit a valuation of around $7 billion, according to a source familiar with the matter, who asked to remain anonymous as they weren't authorized to discuss the information. The company declined to comment on the valuation. "The future of AI will not only live on screens," said David Reger, founder and CEO of Neura Robotics, in a statement. "It will move, interact, learn and work beside us in the real world." The full funding is contingent on Neura hitting certain milestones based on company performance, the source added. Neura declined to comment on the milestones. Investors have piled into robotics startups in recent times as attention turns to deploying AI in physical systems that can interact in real-world environments. Robotics companies have raised $55.8 billion so far in 2026, according to Dealroom, a record figure nearly double the previous record raised last year. The majority of that has been raised by companies in the U.S. and China, but new robotics companies in Europe are also being developed. They include German-based SoftBank-backed Agile Robots and U.K.-based Humanoid. "Many believed globally relevant AI infrastructure companies could only emerge from Silicon Valley," Reger said. "We believe the next generation of AI leaders can emerge anywhere in the world where there is enough vision, engineering talent and execution speed," he added. "With this financing, Neura is firmly among the global leaders in the robotics race, alongside the best in the US and China." Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
The iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) and Vanguard Small-Cap Value ETF (NYSEMKT:VBR) both provide low-cost exposure to small-cap value stocks, but they differ in scale, recent performance, and internal sector weightings. Small-cap value stocks often appeal to investors seeking companies with low valuations relative to their fundamentals. While larger growth stocks frequently d...
The iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) and Vanguard Small-Cap Value ETF (NYSEMKT:VBR) both provide low-cost exposure to small-cap value stocks, but they differ in scale, recent performance, and internal sector weightings. Small-cap value stocks often appeal to investors seeking companies with low valuations relative to their fundamentals. While larger growth stocks frequently dominate headlines, these smaller value plays may offer distinct diversification benefits. This comparison looks at how the iShares and Vanguard offerings navigate this volatile but potentially rewarding market segment. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield. Continue reading
Alex Kelly, global co-chair of the M&A and Private Equity Practice at Latham & Watkins, joins Dani Burger on "Bloomberg Deals." They speak at the SuperReturn conference in Berlin. (Source: Bloomberg)
Alex Kelly, global co-chair of the M&A and Private Equity Practice at Latham & Watkins, joins Dani Burger on "Bloomberg Deals." They speak at the SuperReturn conference in Berlin. (Source: Bloomberg)
Anthropic released Claude Fable , its first Mythos-class AI model, yesterday and it's already causing concerns inside Microsoft. Sources tell me that Microsoft is limiting the use of Claude Fable 5 for employees because of Anthropic's new data retention requirements. While Microsoft quickly rolled out Claude Fable 5 to its GitHub Copilot and Foundry customers, I'm told the model isn't available in...
Anthropic released Claude Fable , its first Mythos-class AI model, yesterday and it's already causing concerns inside Microsoft. Sources tell me that Microsoft is limiting the use of Claude Fable 5 for employees because of Anthropic's new data retention requirements. While Microsoft quickly rolled out Claude Fable 5 to its GitHub Copilot and Foundry customers, I'm told the model isn't available in the model picker that Microsoft employees use for internal versions of GitHub Copilot. All other Claude models are still available internally at Microsoft, because they operate under Zero Data Retention (ZDR) rules. I understand that Microsoft ha … Read the full story at The Verge.
Oselote/iStock via Getty Images The market reaction to Broadcom's ( AVGO ) latest results says more about investor positioning than anything else. The company is reporting record revenues, record operating margins, record AI revenues, record bookings, and providing much more optimistic guidance for the coming quarter. Despite all that, the stock got hammered due to expectations detaching from real...
Oselote/iStock via Getty Images The market reaction to Broadcom's ( AVGO ) latest results says more about investor positioning than anything else. The company is reporting record revenues, record operating margins, record AI revenues, record bookings, and providing much more optimistic guidance for the coming quarter. Despite all that, the stock got hammered due to expectations detaching from reality again. While the decline itself is not particularly interesting, what caught my attention was that Broadcom is likely turning into a key AI infrastructure player from being a beneficiary of the wave. There is a difference between the two. Beneficiaries tend to go through growth waves while infrastructures are often built during their lifetimes. After analyzing the latest earnings call and recent developments, I think that the market is still considering Broadcom a chipmaker while it should see it becoming the coordinator of frontier compute deployments. The Business Is Performing Far Better Than The Narrative Assumes The primary talking point after earnings is why the company chose not to raise its 2027 AI revenue targets above $100 billion and decided to provide $16 billion in guidance for the next quarter compared to whisper numbers that were circulating in the market. While I have a hard time understanding why investors were expecting something different, the numbers provided by Broadcom look really good. First of all, AI semiconductor revenues in Q2 amounted to $10.8 billion and grew 143% yoy. However, what really caught my attention was the bookings level, which was above $30 billion compared to $10.8 billion of shipped revenues. This ratio suggests that the market is not just absorbing all the supplies but is making plans years ahead. The second signal worth focusing on is the customer base, which is increasingly dominated by Google, Anthropic, OpenAI, Meta, and two other undisclosed parties that are not experimental anymore. Broadcom is selling multiple types of ...
Oselote/iStock via Getty Images The market reaction to Broadcom's ( AVGO ) latest results says more about investor positioning than anything else. The company is reporting record revenues, record operating margins, record AI revenues, record bookings, and providing much more optimistic guidance for the coming quarter. Despite all that, the stock got hammered due to expectations detaching from real...
Oselote/iStock via Getty Images The market reaction to Broadcom's ( AVGO ) latest results says more about investor positioning than anything else. The company is reporting record revenues, record operating margins, record AI revenues, record bookings, and providing much more optimistic guidance for the coming quarter. Despite all that, the stock got hammered due to expectations detaching from reality again. While the decline itself is not particularly interesting, what caught my attention was that Broadcom is likely turning into a key AI infrastructure player from being a beneficiary of the wave. There is a difference between the two. Beneficiaries tend to go through growth waves while infrastructures are often built during their lifetimes. After analyzing the latest earnings call and recent developments, I think that the market is still considering Broadcom a chipmaker while it should see it becoming the coordinator of frontier compute deployments. The Business Is Performing Far Better Than The Narrative Assumes The primary talking point after earnings is why the company chose not to raise its 2027 AI revenue targets above $100 billion and decided to provide $16 billion in guidance for the next quarter compared to whisper numbers that were circulating in the market. While I have a hard time understanding why investors were expecting something different, the numbers provided by Broadcom look really good. First of all, AI semiconductor revenues in Q2 amounted to $10.8 billion and grew 143% yoy. However, what really caught my attention was the bookings level, which was above $30 billion compared to $10.8 billion of shipped revenues. This ratio suggests that the market is not just absorbing all the supplies but is making plans years ahead. The second signal worth focusing on is the customer base, which is increasingly dominated by Google, Anthropic, OpenAI, Meta, and two other undisclosed parties that are not experimental anymore. Broadcom is selling multiple types of ...
A joint venture of Mitsubishi UFJ ( MUFG ) and Morgan Stanley ( MS ) targets increasing assets managed for retail clients by JPY 10T ($62B) over the medium to long term, according to a media report. The securities firm and investment bank plans to increase its sales force by several hundred, Reuters reported, citing an interview with Hiroyuki Seki, president of Mitsubishi UFJ Morgan Stanley Securi...
A joint venture of Mitsubishi UFJ ( MUFG ) and Morgan Stanley ( MS ) targets increasing assets managed for retail clients by JPY 10T ($62B) over the medium to long term, according to a media report. The securities firm and investment bank plans to increase its sales force by several hundred, Reuters reported, citing an interview with Hiroyuki Seki, president of Mitsubishi UFJ Morgan Stanley Securities. The push seeks to capitalize as savers shift to higher-yielding investments as deflation, which has been plaguing Japan for decades, ends and interest rates rise. At the end of March, MUMSS had assets under management of JPY 55.9M, Reuters said. The company plans to strengthen its relationship with employees and executives at existing corporate clients and widen its product lines, including by offering loans backed by more types of client assets, Seki told Reuters. On a broader scale, Berkshire Hathaway ( BRK.B ) ( BRK.A ) has been bullish on the Japanese economy, taking at least a 10% stake in each of the country's five big trading houses. More on Mitsubishi UFJ Financial, Morgan Stanley Morgan Stanley (MS) Presents at US Financials Conference 2026 Transcript Morgan Stanley Upgraded To Buy As Q1 Results Drive Bullish Momentum Again Mitsubishi UFJ Financial Group, Inc. 2026 Q4 - Results - Earnings Call Presentation Federal Reserve to release bank stress test results June 24 Morgan Stanley CEO sees $10T potential for wealth management assets alone
Is VST a good stock to buy? We came across a bullish thesis on Vistra Corp. on Darius Dark Investing’s Substack. In this article, we will summarize the bulls’ thesis on VST. Vistra Corp.’s share was trading at $146.22 as of June 9th. VST’s trailing and forward P/E were 24.45 and 16.03 respectively according to Yahoo Finance. […]
Is VST a good stock to buy? We came across a bullish thesis on Vistra Corp. on Darius Dark Investing’s Substack. In this article, we will summarize the bulls’ thesis on VST. Vistra Corp.’s share was trading at $146.22 as of June 9th. VST’s trailing and forward P/E were 24.45 and 16.03 respectively according to Yahoo Finance. […]
imaginima/E+ via Getty Images Introduction I’ve been a long-time O&G bull as I bought shares in many companies in the industry ever since 2021, when they were trading at incredibly low levels. Names include Exxon Mobil Corporation ( XOM ), BP p.l.c. ( BP ), APA Corporation ( APA ) and most recently Permian Resources Corporation ( PR ). I have to be transparent and tell you that I sold all of these...
imaginima/E+ via Getty Images Introduction I’ve been a long-time O&G bull as I bought shares in many companies in the industry ever since 2021, when they were trading at incredibly low levels. Names include Exxon Mobil Corporation ( XOM ), BP p.l.c. ( BP ), APA Corporation ( APA ) and most recently Permian Resources Corporation ( PR ). I have to be transparent and tell you that I sold all of these names in the rally following the drastic increase in crude prices following the war with Iran. Some of these were turnarounds like BP and APA, to which the timeline accelerated, and companies like Permian Resources are incredibly well-run businesses, but the price got ahead of itself. My only remaining exposure to the O&G industry outside of the S&P500 would be midstream firms such as Energy Transfer LP ( ET ) that I’ve held since 2021. I want to dive into why I believe that owning O&G companies or crude is not the best choice on the market. Current Dynamics We’ve just been through one of the largest oil supply shocks on record, with the initial loss of about 10MM bpd of global supply that pushed Brent ( CO1:COM / CL1:COM ) to spike over $100 a barrel. The EIA now assumes that the Middle East production shut-ins averaged 11.3 million b/d in May and are still rising as Iranian storage hits tank tops. WTI is at around $89 and Brent at $92 a barrel, which is sharply down from the April and May averages. This would be linked to the ceasefires after Iran announced the end of its military operations against Israel, with both sides holding fire after a weekend exchange that briefly breached the ceasefire, and Washington and Tehran are reportedly close to an agreement that would extend the truce and reopen the strait even if US President Trump said Iran would pay the price for delaying negotiations for an interim peace deal. OPEC+ also waved through another 188,000 b/d of July quota increases, which is a strong signal of confidence that barrels will need a home again soon. Though ...
Sundry Photography/iStock Editorial via Getty Images J.P. Morgan on Wednesday upgraded Illumina ( ILMN ) to Overweight from Neutral and raised its December 2026 price target to $185 from $125, citing a favorable outlook for the gene sequencing company following a recent customer survey. Analyst Casey Woodring pointed out that JPM’s survey of 62 respondents indicated a growth trajectory in instrume...
Sundry Photography/iStock Editorial via Getty Images J.P. Morgan on Wednesday upgraded Illumina ( ILMN ) to Overweight from Neutral and raised its December 2026 price target to $185 from $125, citing a favorable outlook for the gene sequencing company following a recent customer survey. Analyst Casey Woodring pointed out that JPM’s survey of 62 respondents indicated a growth trajectory in instruments and consumables over the next two years that exceeded Illumina’s ( ILMN ) current organic growth trajectory and its long-term goal of over high-single-digit organic growth. The survey, representing 30 respondents from the research field and 32 from clinical settings, also indicated a potential for Illumina ( ILMN ) to grow its market share in next-generation sequencing, Casey said. JPM projects more than HSD organic growth for ILMN through 2030E, noting its clinical franchise, supported by leading CLIA-certified labs. Having shifted to the company’s NovaSeq X system, those labs "face meaningful switching friction, supporting a stickier-than-appreciated user base and a multi-year test volume runway," Casey added. More on Illumina Illumina, Inc. 2026 Q1 - Results - Earnings Call Presentation Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript Illumina: Competitive Threats Priced In Illumina launches new sequencing tech for molecular residual disease research Here's the full list of business executives invited to go with Trump to China
Fifa still to confirm length of show despite requests Delay is causing issues for advertising teams World Cup TV rights holders are growing increasingly frustrated at Fifa’s failure to confirm the length of the half-time show at next month’s final. Madonna, Shakira and the K-pop boyband BTS have been booked to perform at the MetLife Stadium in the first half-time spectacle at a World Cup final, cu...
Fifa still to confirm length of show despite requests Delay is causing issues for advertising teams World Cup TV rights holders are growing increasingly frustrated at Fifa’s failure to confirm the length of the half-time show at next month’s final. Madonna, Shakira and the K-pop boyband BTS have been booked to perform at the MetLife Stadium in the first half-time spectacle at a World Cup final, curated by Coldplay’s Chris Martin, who put in a surprise performance at last year’s Club World Cup final at the same venue when the break in play lasted 24 minutes. Continue reading...
Is META a good stock to buy? We came across a bullish thesis on Meta Platforms, Inc. on Fundamentally Sound’s Substack. In this article, we will summarize the bulls’ thesis on META. Meta Platforms, Inc.’s share was trading at $584.59 as of June 9th. META’s trailing and forward P/E were 21.29 and 18.62 respectively according to Yahoo […]
Is META a good stock to buy? We came across a bullish thesis on Meta Platforms, Inc. on Fundamentally Sound’s Substack. In this article, we will summarize the bulls’ thesis on META. Meta Platforms, Inc.’s share was trading at $584.59 as of June 9th. META’s trailing and forward P/E were 21.29 and 18.62 respectively according to Yahoo […]
As of midday, the S&P 500 (SNPINDEX:^GSPC) fell 1.00% to 7,312.58, the Nasdaq Composite (NASDAQINDEX:^IXIC) dropped 1.27% to 25,352.11, and the Dow Jones Industrial Average (DJINDICES:^DJI) lost 1.22% to 50,239.76 as hotter inflation and Iran tensions fueled a broad sell-off. AI and chip names remained under heavy pressure this morning, with Super Micro Computer plunging over 17% after announcing ...
As of midday, the S&P 500 (SNPINDEX:^GSPC) fell 1.00% to 7,312.58, the Nasdaq Composite (NASDAQINDEX:^IXIC) dropped 1.27% to 25,352.11, and the Dow Jones Industrial Average (DJINDICES:^DJI) lost 1.22% to 50,239.76 as hotter inflation and Iran tensions fueled a broad sell-off. AI and chip names remained under heavy pressure this morning, with Super Micro Computer plunging over 17% after announcing a $7 billion equity raise. Sector leaders like Nvidia and Micron Technology extended their pullback. Robinhood Markets jumped 6% on a strategic update. Inflation fears and escalating Iran tensions pressured stocks this morning, with the May Consumer Price Index reaching a three-year high of 4.2%. Core inflation, which accounts for everything apart from food and energy, rose 2.9% year on year. Continue reading
James Dolan’s company slams mayor and police commissioner as ‘party poopers’ over large restricted zone The owner of the New York Knicks basketball team sharply criticized both the New York police department and Zohran Mamdani after city officials announced an extensive security strategy for Game 4 of the NBA finals, featuring a large restricted zone and additional access controls. The expanded se...
James Dolan’s company slams mayor and police commissioner as ‘party poopers’ over large restricted zone The owner of the New York Knicks basketball team sharply criticized both the New York police department and Zohran Mamdani after city officials announced an extensive security strategy for Game 4 of the NBA finals, featuring a large restricted zone and additional access controls. The expanded security measures follow Monday’s Game 3 watch party at Bryant Park, where disorder erupted and led to arrests, damage to property, and incidents involving assaults on police officers. Continue reading...
iQoncept/iStock via Getty Images Healthcare exchange-traded funds are attracting renewed investor attention as money continues rotating into defensive sectors. According to recent BofA Research data, healthcare ETFs recorded the largest net inflows among all major market sectors during the latest week, highlighting growing demand for stability amid ongoing concerns about valuations, interest rates...
iQoncept/iStock via Getty Images Healthcare exchange-traded funds are attracting renewed investor attention as money continues rotating into defensive sectors. According to recent BofA Research data, healthcare ETFs recorded the largest net inflows among all major market sectors during the latest week, highlighting growing demand for stability amid ongoing concerns about valuations, interest rates, and economic uncertainty. Against that backdrop, several healthcare-focused ETFs currently carry bullish Seeking Alpha Quant Ratings, reflecting strong momentum and relative performance within the sector. The list is led by the State Street Health Care Select Sector SPDR ETF ( XLV ), which holds a Quant Rating of 3.96. Vanguard Health Care Index Fund ETF ( VHT ) follows with a rating of 3.69, while iShares US Healthcare ETF ( IYH ) and Fidelity MSCI Health Care Index ETF ( FHLC ) are tied at 3.66. The strong ratings among diversified healthcare ETFs come as investors increasingly rotate toward traditionally defensive industries such as pharmaceuticals, managed care, biotechnology, and medical services. Healthcare has historically outperformed during periods of market volatility due to the sector’s relatively stable earnings and cash flow characteristics. Further down the list, iShares Global Healthcare ETF ( IXJ ) carries a more neutral Quant Rating of 3.01, while First Trust Health Care AlphaDEX Fund ETF ( FXH ) sits at 2.76. At the bottom of the screen is iShares US Medical Devices ETF ( IHI ), which holds a Strong Sell Quant Rating of 1.40 after declining 18.04% year to date, reflecting ongoing weakness in parts of the medical device space. Seeking Alpha’s Quant Ratings system evaluates stocks and ETFs based on factors including valuation, growth, momentum, and profitability. Ratings are scored on a scale from 1 to 5, with scores above 3.5 generally considered bullish, while ratings below 2.5 indicate bearish quantitative profiles. Here is the list: State Street Health...
Frasers Group Plc offered to buy Hugo Boss AG in a deal valuing the German fashion brand at about €2.7 billion ($3.1 billion), as billionaire Mike Ashley seeks to add another well-known label to his growing collection. Frasers, the owner of Sports Direct, made a cash bid of €38 a share for Hugo Boss, a premium of 4% to the closing price on Wednesday. Ashley is the controlling shareholder of Fraser...
Frasers Group Plc offered to buy Hugo Boss AG in a deal valuing the German fashion brand at about €2.7 billion ($3.1 billion), as billionaire Mike Ashley seeks to add another well-known label to his growing collection. Frasers, the owner of Sports Direct, made a cash bid of €38 a share for Hugo Boss, a premium of 4% to the closing price on Wednesday. Ashley is the controlling shareholder of Frasers, which already owns a roughly 26% stake in Hugo Boss. The aggregate consideration for the Boss shares not held by Frasers is just under €2 billion, Frasers said. Frasers and Hugo Boss have had a long relationship that includes the British retailer selling the fashion brand’s products in its stores and online.